Antonio Moreno-Valladares, MD, PhD, discusses a recent real-world study of 12-month medication reduction outcomes for patients who have undergone a combined phacoemulsification and ELIOS excimer laser procedure. He describes the parameters of this multicenter study, which followed 112 patients with mild-to-moderate glaucoma and a cataract.
Video: Combined Phacoemulsification and ELIOS for Medication Reduction
Share This Story
Latest News
Join Us for a Symposium During EGS in Dublin
Elios Vision will be hosting a symposium, “Excimer lasers in glaucoma: More than meets the eye,” during the EGS congress in Dublin.
Elios Vision announces collaboration with the International Glaucoma Surgical Registry
Elios Vision will be collaborating with the ISGR, an open-access tool which enables surgeons to compare outcomes with other centres.
Elios Vision achieves three new pipeline milestones
Elios announced enrollment completion in their U.S. pivotal trial, the expansion of the U.S. pre-launch team, and continued commercial uptake in Europe.